Fate Therapeutics Inc (FATE) earnings · rev $6.6M
These earnings events as JSON? API free 100/dayFate Therapeutics Inc (FATE) is a biotechnology company listed on US.
This FATE earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported FATE revenue for 2025-12-31 was $6.6M. Net income was -$136.3M. Revenue was down 51.2% from 2024-12-31 to 2025-12-31. FATE currently screens at market cap $331.0M.
When the next FATE 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 51.2% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full FATE research stays on the stock page; the tape stays on the quote page.
FATE earnings FAQ
What are FATE's latest revenue and net income?
Latest cached Fate Therapeutics Inc (FATE) revenue for Dec 31, 2025 was $6.6M. Net income was -$136.3M. Statements: https://lician.com/financials/fate
What is FATE's latest diluted EPS?
Latest cached Fate Therapeutics Inc (FATE) diluted EPS for Dec 31, 2025 was -$1.15.
What period does the latest FATE earnings print cover?
The latest cached Fate Therapeutics Inc (FATE) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did FATE revenue change from the prior cached period?
Cached Fate Therapeutics Inc (FATE) revenue was down 51.2% from $13.6M (Dec 31, 2024) to $6.6M (Dec 31, 2025). Statements: https://lician.com/financials/fate
Where are FATE earnings listed?
Cached earnings facts for Fate Therapeutics Inc (FATE) are listed at https://lician.com/earnings/fate. Statements: https://lician.com/financials/fate
Not investment advice.